BioGeneration Ventures (BGV) is a venture capital firm specializing in seed and early-stage investments in European biotech, medtech, and diagnostics companies. It is the early-stage strategy within the Forbion-BGV platform of funds, having managed over €400 million across five funds.
60% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (1 deal in the last 12 months vs 3 prior). Their most common stage is series-a (48% of deals). Average disclosed round size is $65.1M (across 11 rounds with reported amounts).
Portfolio
28
Fund Size
$167.9M
Top Stage
Series A
Last 12 Mo
1
Team
Daniela Couto, PhD
General Partner
Keno Gutierrez, PhD
General Partner
Arnoud Dijkstra, PhD
Venture Partner
Elena Ritsou , PhD
Venture Partner
Diede Brunen, PhD
Principal
Cyril Lesser, MSc, LLM
Vice President Finance | Funds
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Mironid | Series B | $46M | Aug 2026 |
| RRhyGaze AG | Series A | $86M | Jan 2025 |
 Citryll | Series B | — | Dec 2024 |
 KIVU BIOSCIENCE | Series A | $92M | Oct 2024 |
 Brenig Therapeutics | Series A | $65M | Jul 2024 |
 Confo Therapeutics | Series B | — | Jan 2024 |
| VVectorY Therapeutics | Series A | $138M | Nov 2023 |
| Mironid | Series A | — | Sep 2023 |
 Complement Therapeutics | Series A | — | Apr 2023 |
| CComplement | Series A | — | Apr 2023 |
| VVarmX BV | Series A | — | Jan 2023 |
 Artica Therapeutics | Pre-Seed | — | Jan 2023 |
| VVectorY Therapeutics | Series A | $129M | Jan 2023 |
 Scenic Biotech BV | Series A | $31M | Mar 2022 |
| VVectorY Therapeutics | Seed | — | Jun 2021 |
 VectorY | Seed | — | Jun 2021 |
 Mellon Medical B.V. | Series B | — | Jun 2020 |
 Azafaros | Series A | — | Feb 2020 |
| Confo Therapeutics | Series A | — | May 2019 |
 Mellon Medical | Unknown | — | Oct 2017 |
| Mellon Medical | Unknown | — | Jan 2017 |
| DDezima Pharma | Series A | — | Feb 2013 |
 Acerta Pharma | Series A | $13M | Jan 2013 |
| DDezima Pharma | Seed | — | Jan 2012 |
| LLanthio | Seed | — | Jan 2011 |
Top Co-Investors
Last updated: 7 October 2026